Vascular Endothelial Growth Factor Inhibitors and Artery dissections and aneurysms - An analysis of EudraVigilance

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/39118
• EU PAS number:
  EUPAS39117
• Study ID:
  39118
• Official title and acronym:
  Vascular Endothelial Growth Factor Inhibitors and Artery dissections and aneurysms - An analysis of EudraVigilance
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  This was a descriptive study of case reports of artery dissections and aneurysms with vascular endothelial growth factor inhibitors using EudraVigilance data.
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 06/12/2018

Actual: 07/12/2018

Study start date

Planned: 07/12/2018

Actual: 07/12/2018

Data analysis start date

Planned: 07/12/2018

Actual: 07/12/2018

Date of interim report, if expected

Planned: 30/01/2019

Actual: 11/02/2019

Date of final study report

Planned: 13/02/2019

Actual: 18/02/2019

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable